文献速递乳腺乳腺X线

同一乳腺不同部位可疑钙化DBT引导VAB:是否需多点活检?

Digital breast tomosynthesis-guided vacuum-assisted biopsy of suspicious calcifications at different sites within one breast: Is biopsy of more than one location needed?
PubMed 文献 · Eur J Radiol · 2022-07-28

本研究纳入21例同一乳腺内两个不同部位BI-RADS≥4b钙化并接受DBT引导真空辅助活检的患者,分析两部位病理及临床管理是否一致。结果显示57%患者两部位管理相同,43%不同,其中4例高风险病变对良性改变,2例高级别DCIS对良性改变,3例浸润癌伴高级别DCIS对纯高级别DCIS。提示同侧乳腺多点可疑钙化即使形态相似也可能病理不同,应考虑多点活检。

要点

  • 同侧乳腺两个不同部位BI-RADS≥4b钙化,43%患者病理导致临床管理不同。
  • 多点钙化形态相似或可疑度相同,仍可能分别为高风险/恶性与良性。
  • 对同侧乳腺多处可疑钙化,建议考虑对不止一个部位进行活检。

局限性

  • 单中心回顾性研究,样本量小(21例)。
  • 仅纳入两个不同部位钙化且接受DBT引导VAB的患者,存在选择偏倚。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: To investigate how often biopsy of two sites of morphologically similar or equally suspicious calcifications within the same breast yield differing histopathologic results, and how this may affect clinical management.

MATERIALS AND METHODS: We identified patients with two or more sites of calcifications categorized as Breast Imaging Reporting and Data System (BI-RADS) ≥ 4b within the same breast who underwent digital breast tomosynthesis-guided vacuum-assisted biopsy (DBT-guided VAB). We analyzed how often biopsy of two distinct sites yielded the same or differing histopathologic findings. The histopathologic findings were dichotomized into "actionable" and "non-actionable", depending on the respective further management. We then analyzed how often the consecutive management would have been the same or different.

RESULTS: Of 206 women undergoing DBT-guided VAB at our institution within 24 months, 21 consecutive patients (54 ± 10.2 years; range: 35-71) underwent DBT-guided VAB of two distinct sites of calcifications. Management of histologic findings was the same (both sites actionable or both sites non-actionable) in 12/21 (57 %), different in the remaining 9/21 patients (43 %). Of the nine patients whose differing histologic findings would have led to different clinical management, 4/9 had a high-risk lesion (atypical ductal hyperplasia n = 3, papilloma with epithelial atypia n = 1) vs benign changes (adenosis n = 4), 2/9 had high-grade DCIS vs benign changes (adenosis n = 1, fat necrosis n = 1), and 3/9 had invasive cancer (luminal A n = 2, luminal B n = 1) with high-grade DCIS vs pure high-grade DCIS.

CONCLUSIONS: Multiple sites of calcifications within the same breast, even when morphologically similar or equally suspicious, may represent different histopathologic findings with different clinical management implications. Accordingly, in the presence of suspicious calcifications at multiple distinct sites within the same breast, biopsy of more than one site of calcification should be considered.

来源:Eur J Radiol,查看原文。版权归原作者所有。

引用

  1. Bode, Charlotte Huck, Raaff, et al. Digital breast tomosynthesis-guided vacuum-assisted biopsy of suspicious calcifications at different sites within one breast: Is biopsy of more than one location needed? Eur J Radiol. 2022. PMID: 35914364. doi:10.1016/j.ejrad.2022.110456

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。